Winthrop Advisory Group LLC Seagen Inc. Transaction History

Winthrop Advisory Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$187.64 - $206.25 $5,629 - $6,187	30 Added 1.17%	2,598 $500,000
Q1 2023 Apr 17, 2023	SELL	$127.59 - $203.08 $318,975 - $507,700	-2,500 Reduced 49.33%	2,568 $519,000
Q4 2022 Aug 03, 2023	BUY	$117.37 - $139.17 $289,903 - $343,749	2,470 Added 95.07%	5,068 $651,000
Q4 2022 Jan 18, 2023	BUY	$117.37 - $139.17 $594,831 - $705,313	5,068 New	5,068 $651,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Winthrop Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on Winthrop Advisory Group LLC with notifications on news.